Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Noble

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 1, 2021
Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free SurvivalD J Noble, E Doyle, G Tramonti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 20, 2017
Reduction in Total Radiation Exposure Using X-ray Image Guidance Illustrated in a Patient Receiving Pituitary RadiotherapyF Brochu, M Romanchikova, S J Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2017
Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapyL E A Shelley, J E Scaife, M Romanchikova, et al.
Physics in Medicine and Biology|June 3, 2017
Automatic contour propagation using deformable image registration to determine delivered dose to spinal cord in head-and-neck cancer radiotherapyP L Yeap, D J Noble, K Harrison, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2024
The UK Divide: Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in ScotlandA Thapa, A Cowell, A Peters, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 1, 2021
Defining Biochemical Cure After Low Dose Rate Prostate Brachytherapy: External Validation of 4-year Prostate-specific Antigen Nadir as a Predictor of 10- and 15-year Disease-free SurvivalD J Noble, E Doyle, G Tramonti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 20, 2017
Reduction in Total Radiation Exposure Using X-ray Image Guidance Illustrated in a Patient Receiving Pituitary RadiotherapyF Brochu, M Romanchikova, S J Thomas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 3, 2017
Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapyL E A Shelley, J E Scaife, M Romanchikova, et al.
Physics in Medicine and Biology|June 3, 2017
Automatic contour propagation using deformable image registration to determine delivered dose to spinal cord in head-and-neck cancer radiotherapyP L Yeap, D J Noble, K Harrison, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|February 23, 2024
The UK Divide: Does Having a Pembrolizumab-Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab-Chemotherapy Combination in ScotlandA Thapa, A Cowell, A Peters, et al.
Pageof 2